These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5372934)

  • 21. Nasal mucous membrane in atrophic rhinitis with reference to symptomfree nasal mucosa. Histology, histochemistry and exfoliative cytology.
    Holopainen E
    Acta Otolaryngol; 1967; ():Suppl 227:1-55. PubMed ID: 4871493
    [No Abstract]   [Full Text] [Related]  

  • 22. [Bacteriological study of nasal smear samples from healthy pigs and pigs with atrophic rhinitis].
    Schöss P
    Dtsch Tierarztl Wochenschr; 1971 Jul; 78(13):371-4. PubMed ID: 4932101
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of ozena by infiltration of the nasal mucosa with streptomycin and novocaine].
    Kitanoski B; Obradović D; Haralampiev K; Tatić V
    Vojnosanit Pregl; 1985; 42(5):336-9. PubMed ID: 4095927
    [No Abstract]   [Full Text] [Related]  

  • 24. [The bases of the problem of surgical narrowing of the nose in ozena].
    Eckert-Möbius A
    HNO; 1965 Dec; 13(12):350-2. PubMed ID: 5871153
    [No Abstract]   [Full Text] [Related]  

  • 25. [Protein composition and pH of nasal secretion in patients suffering from rhinitis].
    Plotnikova NE
    Vestn Otorinolaringol; 1971; 33(5):20-5. PubMed ID: 5152555
    [No Abstract]   [Full Text] [Related]  

  • 26. [The ozena face].
    Oltersdorf U; Kallidis J
    Arch Ohren Nasen Kehlkopfheilkd; 1965; 185(2):746-51. PubMed ID: 5881113
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug recalibration of nasal cavity in ozena].
    Müllfay VV
    HNO; 1970 Sep; 18(9):274-6. PubMed ID: 5513832
    [No Abstract]   [Full Text] [Related]  

  • 28. [Deficiency of protease inhibitors in nasal secretions of patients with ozeana].
    Reichert R; Hochstrasser K
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1972; 201(1):11-6. PubMed ID: 5015206
    [No Abstract]   [Full Text] [Related]  

  • 29. [Late results of ozena treatment by means of the Eyriès method].
    Durska-Zakrzewska A
    Otolaryngol Pol; 1966; 20(2):277-82. PubMed ID: 5913373
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sialic acid levels in patients with ozena].
    Kossowski S; Mikulewicz W; Greczek-Harkawy J
    Otolaryngol Pol; 1972; 26(4):395-8. PubMed ID: 5073473
    [No Abstract]   [Full Text] [Related]  

  • 31. [Microscopic investigations of the mucous membrane of the nose in patients with ozena treated surgically by means of the Eyriès method].
    Durska-Zakrzewska A; Groniowski J
    Otolaryngol Pol; 1966; 20(2):283-9. PubMed ID: 5913374
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the characteristics of the hydrogen index of the secretions of the mucous membrane of the nasal cavity in miners].
    Brofman AV
    Vestn Otorinolaringol; 1967; 29(2):29-32. PubMed ID: 5616664
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on proteins of nasal mucous membrane secretion in fibrinolytic aspect.
    Mikulewicz W; Kubik K; Bednarski W
    Acta Otolaryngol; 1970; 70(5):379-82. PubMed ID: 5505134
    [No Abstract]   [Full Text] [Related]  

  • 34. [Control investigations of changes of certain oxidoreductive enzymes in nasal mucosa in surgically treated patients with ozena (author's transl)].
    Hajac T; Kossowski S; Greczek-Harkawy J; Rak J
    Otolaryngol Pol; 1980; 34(2-3):173-82. PubMed ID: 7443245
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of our ozena operations during the past 15 years].
    Pozsgay J; Heckenast O; Moharos J
    Monatsschr Ohrenheilkd Laryngorhinol; 1967; 101(4):165-71. PubMed ID: 5586339
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cytological evaluation of nasal mucosal variability in surgically treated patients with ozena].
    Makowska W; Fruba J
    Otolaryngol Pol; 1991; 45(1):39-42. PubMed ID: 2052368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nasal ozena within the framework of autoimmune diseases (clinical and experimental studies)].
    Nardi F; Vangelista A
    Quad Sclavo Diagn; 1973 Sep; 9(3):801-10. PubMed ID: 4368192
    [No Abstract]   [Full Text] [Related]  

  • 38. Ozena revisited.
    Zohar Y; Talmi YP; Strauss M; Finkelstein Y; Shvilli Y
    J Otolaryngol; 1990 Oct; 19(5):345-9. PubMed ID: 2262956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contribution to the concomitant flora in ozena].
    Mros B; Wemmer H
    HNO; 1967 May; 15(5):131-6. PubMed ID: 5584596
    [No Abstract]   [Full Text] [Related]  

  • 40. [Low-energy laser radiation in the combined therapy of ozena patients].
    Bikbaeva AI; Sharipov RA
    Vestn Otorinolaringol; 1986; (3):59-61. PubMed ID: 3727272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.